Antipsychotic Polypharmacy: Correlates, Evidence and Outcomes

Dates and Times

Start: 9/26/2023 11:00 AM
End: 9/26/2023 12:00 PM

Objectives

1) To discuss frequency of and reasons for polypharmacy in the treatment of schizophrenia

2) To evaluate the evidence base for the efficacy and safety of polypharmacy strategies involving agents from the same and from different medication classes

3) To identify appropriate patients and clinical scenarios for combination and augmentation strategies in the management of patients with schizophrenia with insufficient response to antipsychotic monotherapy

Grand Round Files

Speakers

Accreditation

The School of Medicine, State University of New York at Stony Brook, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The School of Medicine, State University of New York at Stony Brook designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ^™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.